Predicting Treatment Response in Patients With OCD

NCT03993535 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: selective serotonin reuptake inhibitor

Sponsor

University of Sao Paulo

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]